Anthracycline extravasation: a comprehensive review of experimental and clinical treatments

Publikation: Bidrag til tidsskrift › Review › Forskning › fagfællebedømt

Standard

Anthracycline extravasation : a comprehensive review of experimental and clinical treatments. / Langer, Seppo W; Sehested, Maxwell; Jensen, Peter Buhl.

I: Tumori, Bind 95, Nr. 3, 20.08.2009, s. 273-82.

Publikation: Bidrag til tidsskrift › Review › Forskning › fagfællebedømt

Harvard

Langer, SW, Sehested, M & Jensen, PB 2009, 'Anthracycline extravasation: a comprehensive review of experimental and clinical treatments', Tumori, bind 95, nr. 3, s. 273-82.

APA

Langer, S. W., Sehested, M., & Jensen, P. B. (2009). Anthracycline extravasation: a comprehensive review of experimental and clinical treatments. Tumori, 95(3), 273-82.

Vancouver

Langer SW, Sehested M, Jensen PB. Anthracycline extravasation: a comprehensive review of experimental and clinical treatments. Tumori. 2009 aug. 20;95(3):273-82.

Author

Langer, Seppo W ; Sehested, Maxwell ; Jensen, Peter Buhl. / Anthracycline extravasation : a comprehensive review of experimental and clinical treatments. I: Tumori. 2009 ; Bind 95, Nr. 3. s. 273-82.

Bibtex

@article{e373e5a48ba044959dde0d9044219e64,
title = "Anthracycline extravasation: a comprehensive review of experimental and clinical treatments",
abstract = "An accidental extravasation of anthracycline-containing chemotherapy is a feared complication that may lead to necrosis and severe tissue destruction. For four decades, much effort has been done to prevent and treat this devastating condition. Savene has recently been proved to be very effective, and is the only approved treatment against anthracyline extravasation. It is thus now widely recommended. The present article represents a comprehensive review of, and historical insight to, the experimental and clinical studies of surgical and non-surgical treatments of extravasation during forty years of clinical anthracycline treatment.",
keywords = "Adrenal Cortex Hormones/therapeutic use, Animals, Anthracyclines/administration & dosage, Antibiotics, Antineoplastic/administration & dosage, Bicarbonates/therapeutic use, Dimethyl Sulfoxide/therapeutic use, Extravasation of Diagnostic and Therapeutic Materials/drug therapy, Fibroblast Growth Factor 2/therapeutic use, Granulocyte Colony-Stimulating Factor/therapeutic use, Granulocyte-Macrophage Colony-Stimulating Factor/therapeutic use, Humans, Hyaluronoglucosaminidase/therapeutic use, Necrosis/chemically induced, Razoxane/therapeutic use, Skin Diseases/chemically induced, Ulcer/chemically induced, alpha-Tocopherol/therapeutic use",
author = "Langer, {Seppo W} and Maxwell Sehested and Jensen, {Peter Buhl}",
year = "2009",
month = aug,
day = "20",
language = "English",
volume = "95",
pages = "273--82",
journal = "Tumori",
issn = "0300-8916",
publisher = "Wichtig Publishing",
number = "3",

}

RIS

TY - JOUR

T1 - Anthracycline extravasation

T2 - a comprehensive review of experimental and clinical treatments

AU - Langer, Seppo W

AU - Sehested, Maxwell

AU - Jensen, Peter Buhl

PY - 2009/8/20

Y1 - 2009/8/20

N2 - An accidental extravasation of anthracycline-containing chemotherapy is a feared complication that may lead to necrosis and severe tissue destruction. For four decades, much effort has been done to prevent and treat this devastating condition. Savene has recently been proved to be very effective, and is the only approved treatment against anthracyline extravasation. It is thus now widely recommended. The present article represents a comprehensive review of, and historical insight to, the experimental and clinical studies of surgical and non-surgical treatments of extravasation during forty years of clinical anthracycline treatment.

AB - An accidental extravasation of anthracycline-containing chemotherapy is a feared complication that may lead to necrosis and severe tissue destruction. For four decades, much effort has been done to prevent and treat this devastating condition. Savene has recently been proved to be very effective, and is the only approved treatment against anthracyline extravasation. It is thus now widely recommended. The present article represents a comprehensive review of, and historical insight to, the experimental and clinical studies of surgical and non-surgical treatments of extravasation during forty years of clinical anthracycline treatment.

KW - Adrenal Cortex Hormones/therapeutic use

KW - Animals

KW - Anthracyclines/administration & dosage

KW - Antibiotics, Antineoplastic/administration & dosage

KW - Bicarbonates/therapeutic use

KW - Dimethyl Sulfoxide/therapeutic use

KW - Extravasation of Diagnostic and Therapeutic Materials/drug therapy

KW - Fibroblast Growth Factor 2/therapeutic use

KW - Granulocyte Colony-Stimulating Factor/therapeutic use

KW - Granulocyte-Macrophage Colony-Stimulating Factor/therapeutic use

KW - Humans

KW - Hyaluronoglucosaminidase/therapeutic use

KW - Necrosis/chemically induced

KW - Razoxane/therapeutic use

KW - Skin Diseases/chemically induced

KW - Ulcer/chemically induced

KW - alpha-Tocopherol/therapeutic use

M3 - Review

C2 - 19688963

VL - 95

SP - 273

EP - 282

JO - Tumori

JF - Tumori

SN - 0300-8916

IS - 3

ER -

ID: 247891329